[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 4 of about 4
1. Biecker E, Fischer HP, Strunk H, Sauerbruch T: Benign hepatic tumours. Z Gastroenterol; 2003 Feb;41(2):191-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Due to advances in imaging procedures like MRI, Cf-scan and ultrasound as well as progress in immunohistochemistry, the appropriate diagnosis is made ina high percentage of patients without laparotomy and resection.
  • Most important in clinical practice is the differential diagnosis of focal nodular hyperplasia and hepatocellular adenoma because of the risk of rupture and bleeding in the latter.
  • The diagnosis of nodular regenerative hyperplasia is often missed and patients present with secondary complications and signs of portal hypertension that necessitate treatment.
  • The main problem in angiomyolipoma is to distinguish it from malignant processes which do require treatment.
  • Because of its clinical presentation, inflammatory pseudotumour is also sometimes confused with a malignant tumour.
  • Therapeutic options are drug therapy or surgical resection.
  • Bile duct adenoma is an incidental finding that is not known to cause any symptoms whereas biliary cystadenoma is often symptomatic and may progress to cystadenocarcinoma and therefore needs resection.
  • [MeSH-major] Liver Diseases / diagnosis. Liver Neoplasms / diagnosis
  • [MeSH-minor] Adenoma, Liver Cell / diagnosis. Adenoma, Liver Cell / pathology. Adult. Aged. Diagnostic Imaging. Focal Nodular Hyperplasia / diagnosis. Focal Nodular Hyperplasia / pathology. Granuloma, Plasma Cell / diagnosis. Granuloma, Plasma Cell / pathology. Hemangioendothelioma / diagnosis. Hemangioendothelioma / pathology. Hemangioma, Cavernous / diagnosis. Hemangioma, Cavernous / pathology. Humans. Infant. Liver / pathology. Liver Regeneration / physiology. Middle Aged

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12650132.001).
  • [ISSN] 0044-2771
  • [Journal-full-title] Zeitschrift für Gastroenterologie
  • [ISO-abbreviation] Z Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 138
  •  go-up   go-down


2. O'Grady JG: Treatment options for other hepatic malignancies. Liver Transpl; 2000 Nov;6(6 Suppl 2):S23-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • 3. The role of liver transplantation in the management of cholangiocarcinoma is limited by the perception that it is inappropriate to use scarce organs when 5-year survival rates are 25%.
  • 4. Liver transplantation is an important intervention in patients with tumors that remain unresectable after chemotherapy.
  • The role of liver transplantation in patients with extrahepatic disease that responds to chemotherapy is controversial.
  • Careful timing of surgery is required to avoid secondary drug resistance.
  • 5. Liver transplantation has been successfully applied to a range of rare hepatic malignancies, but small numbers preclude strong recommendations on the appropriateness of this practice.
  • [MeSH-major] Liver Neoplasms / therapy. Liver Transplantation
  • [MeSH-minor] Bile Duct Neoplasms / therapy. Bile Ducts, Intrahepatic. Cholangiocarcinoma / diagnosis. Cholangiocarcinoma / surgery. Cholangiocarcinoma / therapy. Combined Modality Therapy. Cystadenocarcinoma / therapy. Genetic Therapy. Hemangioendothelioma / therapy. Hemangiosarcoma / therapy. Hepatoblastoma / therapy. Humans. Neuroendocrine Tumors / therapy. Palliative Care

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Liver Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11084081.001).
  • [ISSN] 1527-6465
  • [Journal-full-title] Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • [ISO-abbreviation] Liver Transpl.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] UNITED STATES
  • [Number-of-references] 26
  •  go-up   go-down


3. Xu HX: Contrast-enhanced ultrasound in the biliary system: Potential uses and indications. World J Radiol; 2009 Dec 31;1(1):37-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contrast-enhanced ultrasound in the biliary system: Potential uses and indications.
  • Conventional ultrasound (US) is the first-line imaging investigation for biliary diseases.
  • However, it is lack of the ability to depict the microcirculation of some lesions which may lead to failure in diagnosis for some biliary diseases.
  • The use of contrast-enhanced US (CEUS) has reached the field of bile duct disease in recent years and promising results have been achieved.
  • In this review, the methodology, image interpretation, enhancement pattern, clinical usefulness, and indications for CEUS in the biliary system are summarized.
  • CEUS may be indicated in the biliary system under the following circumstances:.
  • (2) For differentiation diagnosis between ICC and other tumors (i.e. hepatocellular carcinoma or liver metastasis) or infectious diseases;.
  • (3) For differentiation diagnosis between biliary cystadenoma and biliary cystadenocarcinoma;.
  • (4) To detect malignant change in Caroli's disease;.
  • (8) For differentiation diagnosis between motionless sludge and gallbladder cancer;.
  • (9) For differentiation diagnosis between common bile duct cancer and sludge or stone without acoustic shadowing; and (10) In patients who are suspected of having a drop of their percutaneous transhepatic cholangiodrainage tube, US contrast agent can be administered to through the tube detect the site of the tube.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21160719.001).
  • [ISSN] 1949-8470
  • [Journal-full-title] World journal of radiology
  • [ISO-abbreviation] World J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2999303
  • [Keywords] NOTNLM ; Bile duct / Cholangiocarcinoma / Contrast-enhanced ultrasound / Gallbladder / Polypoid lesion / Ultrasound contrast agent
  •  go-up   go-down


Advertisement
4. Ren XL, Yan RL, Yu XH, Zheng Y, Liu JE, Hou XB, Zuo SY, Fu XY, Chang H, Lu JH: Biliary cystadenocarcinoma diagnosed with real-time contrast-enhanced ultrasonography: report of a case with diagnostic features. World J Gastroenterol; 2010 Jan 7;16(1):131-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biliary cystadenocarcinoma diagnosed with real-time contrast-enhanced ultrasonography: report of a case with diagnostic features.
  • Biliary cystadenocarcinoma is a very rare malignant cystic tumor of the liver, which is often misdiagnosed due to a poor recognition of it.
  • We report a case of a 60-year-old man with biliary cystadenocarcinoma with his real time contrast enhanced ultrasound (CEUS) characteristics compared to those of computed tomography (CT) and magnetic resonance imaging (MRI), which were correlated with the surgical and pathologic findings.
  • Cystic wall enhancement, internal septations and intra-cystic solid portions in the arterial phase were observed on CEUS after contrast agent injection.
  • CT revealed a large irregular cystic lesion in the left liver lobe with no clear septations and solid components.
  • MRI showed an irregular cystic occupying lesion with septations.
  • [MeSH-major] Biliary Tract Neoplasms / ultrasonography. Contrast Media. Cystadenocarcinoma / ultrasonography. Liver Neoplasms / ultrasonography. Phospholipids. Sulfur Hexafluoride. Ultrasonography, Doppler, Color

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. SULFUR HEXAFLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1981 Jun 15;47(12):2936-40 [7260880.001]
  • [Cites] AJR Am J Roentgenol. 1981 Feb;136(2):345-8 [6258409.001]
  • [Cites] Cancer. 1985 Sep 15;56(6):1434-45 [4027877.001]
  • [Cites] Cancer. 1988 Mar 1;61(5):941-6 [3276394.001]
  • [Cites] Radiology. 1989 Apr;171(1):57-61 [2648477.001]
  • [Cites] Ann Surg. 1990 Jan;211(1):18-27 [2403772.001]
  • [Cites] Cancer. 1992 May 15;69(10):2426-32 [1314687.001]
  • [Cites] Am J Surg Pathol. 1994 Nov;18(11):1078-91 [7943529.001]
  • [Cites] Semin Liver Dis. 1995 Nov;15(4):402-13 [8578323.001]
  • [Cites] J Gastroenterol. 1996 Oct;31(5):732-6 [8887044.001]
  • [Cites] Clin Radiol. 1997 Apr;52(4):318-21 [9112957.001]
  • [Cites] Eur J Cancer. 1998 Nov;34(12):1845-51 [10023304.001]
  • [Cites] J Ultrasound Med. 2004 Dec;23(12):1557-68 [15557299.001]
  • [Cites] J Ultrasound Med. 2005 Mar;24(3):285-97 [15723841.001]
  • [Cites] Korean J Gastroenterol. 2006 Jan;47(1):52-8 [16434869.001]
  • [Cites] Tumori. 2006 Jul-Aug;92(4):358-60 [17036531.001]
  • [Cites] J Ultrasound Med. 2008 Feb;27(2):243-54 [18204015.001]
  • [Cites] Can J Surg. 2001 Oct;44(5):371-6 [11603751.001]
  • [Cites] Radiology. 2004 Aug;232(2):420-30 [15286314.001]
  • [Cites] Surgery. 2004 Oct;136(4):926-36 [15467680.001]
  • [Cites] Cancer. 1977 Jan;39(1):322-38 [318915.001]
  • [Cites] AJR Am J Roentgenol. 1980 Oct;135(4):723-7 [6778105.001]
  • [Cites] Radiology. 1983 May;147(2):485-90 [6300962.001]
  • (PMID = 20039461.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Phospholipids; 0 / contrast agent BR1; WS7LR3I1D6 / Sulfur Hexafluoride
  • [Other-IDs] NLM/ PMC2799910
  •  go-up   go-down






Advertisement